New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 17  •  04:00PM ET
13.70
Dollar change
-0.10
Percentage change
-0.72
%
IndexRUT P/E22.01 EPS (ttm)0.62 Insider Own4.01% Shs Outstand22.29M Perf Week3.32%
Market Cap305.40M Forward P/E14.68 EPS next Y0.93 Insider Trans-1.88% Shs Float21.40M Perf Month8.90%
Enterprise Value266.04M PEG0.72 EPS next Q0.17 Inst Own100.94% Short Float9.94% Perf Quarter39.65%
Income15.11M P/S1.02 EPS this Y-11.43% Inst Trans-3.93% Short Ratio9.59 Perf Half Y0.29%
Sales298.85M P/B1.57 EPS next Y50.54% ROA5.48% Short Interest2.13M Perf YTD-20.02%
Book/sh8.74 P/C3.75 EPS next 5Y30.62% ROE7.64% 52W High21.10 -35.07% Perf Year-1.15%
Cash/sh3.66 P/FCF7.71 EPS past 3/5Y- 4.69% ROIC6.54% 52W Low8.61 59.12% Perf 3Y57.11%
Dividend Est.- EV/EBITDA10.36 Sales past 3/5Y12.09% 9.11% Gross Margin73.88% Volatility2.89% 2.78% Perf 5Y-60.99%
Dividend TTM- EV/Sales0.89 EPS Y/Y TTM-54.24% Oper. Margin6.30% ATR (14)0.42 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.36 Sales Y/Y TTM6.15% Profit Margin5.06% RSI (14)62.69 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio3.79 EPS Q/Q-22.42% SMA202.78% Beta1.04 Target Price13.50
Payout0.00% Debt/Eq0.22 Sales Q/Q7.77% SMA5015.21% Rel Volume0.75 Prev Close13.80
Employees1037 LT Debt/Eq0.19 EarningsAug 04 AMC SMA2001.08% Avg Volume221.89K Price13.70
IPOJul 28, 2016 Option/ShortYes / Yes EPS/Sales Surpr.30.23% 6.72% Trades Volume166,059 Change-0.72%
Date Action Analyst Rating Change Price Target Change
May-06-25Downgrade Piper Sandler Overweight → Neutral $14
Feb-19-25Downgrade B. Riley Securities Buy → Neutral $23 → $18
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Aug-07-19Upgrade BTIG Research Neutral → Buy $62
Jun-13-19Initiated Dougherty & Company Buy $80
Jan-02-19Upgrade Northland Capital Under Perform → Market Perform
Sep-08-25 04:59PM
04:34PM
Aug-22-25 09:40AM
Aug-06-25 09:40AM
09:35AM
09:30AM Loading…
09:30AM
Aug-05-25 03:05AM
Aug-04-25 05:35PM
04:35PM
04:05PM
Jul-30-25 05:15PM
Jul-21-25 04:05PM
Jul-14-25 07:23AM
Jun-03-25 08:00AM
May-20-25 04:05PM
12:09PM Loading…
May-06-25 12:09PM
03:08AM
May-05-25 05:30PM
04:27PM
04:05PM
May-02-25 09:33AM
Apr-30-25 05:50PM
Apr-21-25 04:05PM
Apr-07-25 12:58PM
Mar-05-25 04:05PM
Feb-19-25 11:23AM
02:06AM
Feb-18-25 07:20PM
06:17PM
04:05PM
02:52AM Loading…
02:52AM
Feb-05-25 04:05PM
Feb-04-25 08:00AM
Jan-13-25 08:00AM
Jan-01-25 09:40AM
Dec-16-24 03:34PM
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
05:11PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
May-07-24 10:48AM
07:04AM
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
Apr-15-24 04:05PM
Apr-12-24 05:45PM
01:53PM
Apr-03-24 12:00PM
Apr-01-24 09:40AM
Mar-14-24 09:40AM
Mar-13-24 09:55AM
Feb-27-24 09:40AM
Feb-26-24 09:55AM
Feb-23-24 09:55AM
Feb-21-24 09:26AM
Feb-20-24 10:39PM
06:34PM
08:40AM
08:11AM
07:38AM
07:30AM
Feb-05-24 04:05PM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dodd Sheri LouiseChief Executive OfficerAug 08 '25Sale12.367,76295,907173,479Aug 12 06:03 PM
Dodd Sheri LouiseOfficerAug 08 '25Proposed Sale12.367,76295,906Aug 08 03:40 PM
Birkemeyer Elaine M.Chief Financial OfficerMay 12 '25Sale9.942,92129,03799,111May 14 05:26 PM
Birkemeyer Elaine M.OfficerMay 12 '25Proposed Sale9.942,92129,037May 12 05:25 PM
Dodd Sheri LouiseChief Executive OfficerMay 08 '25Sale9.833,14930,955181,241May 12 04:34 PM
BURKE WILLIAM WDirectorMay 08 '25Sale9.673,30031,91148,520May 09 04:28 PM
Dodd Sheri LouiseDirectorMay 08 '25Proposed Sale9.833,14930,955May 08 07:17 PM
BURKE WILLIAM WDirectorMay 08 '25Proposed Sale9.673,30031,911May 08 04:46 PM
Ferstler Sherri LeeOfficerApr 03 '25Proposed Sale13.142,35530,945Apr 03 05:30 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 25 '25Sale14.512,06629,980102,032Feb 27 04:29 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 25 '25Sale14.406,46893,16077,540Feb 27 04:28 PM
REUVERS DANIEL L.DirectorFeb 25 '25Sale14.1828,338401,850214,604Feb 27 04:27 PM
REUVERS DANIEL L.OfficerFeb 25 '25Proposed Sale14.1828,338401,851Feb 25 07:35 PM
Burns KristieOfficerFeb 25 '25Proposed Sale14.406,46893,160Feb 25 07:15 PM
Birkemeyer Elaine M.OfficerFeb 25 '25Proposed Sale14.512,06629,980Feb 25 06:54 PM
REUVERS DANIEL L.DirectorFeb 24 '25Sale14.5510,938159,147242,942Feb 24 06:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 24 '25Sale14.654,83070,75384,008Feb 24 06:23 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 24 '25Sale14.703,77855,538104,098Feb 24 06:22 PM
REUVERS DANIEL L.OfficerFeb 24 '25Proposed Sale14.5510,938159,147Feb 24 05:23 PM
Burns KristieOfficerFeb 24 '25Proposed Sale14.654,83070,753Feb 24 05:12 PM
Ferstler Sherri LeeOfficerFeb 24 '25Proposed Sale14.792,20932,660Feb 24 04:58 PM
Birkemeyer Elaine M.OfficerFeb 24 '25Proposed Sale14.703,77855,538Feb 24 04:55 PM